SURGICAL INNOVATION AND ITS EVALUATION

被引:38
作者
BUNKER, JP
HINKLEY, D
MCDERMOTT, WV
机构
[1] UNIV MINNESOTA, MINNEAPOLIS, MN 55455 USA
[2] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA
关键词
D O I
10.1126/science.347581
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Early clinical trials, observational or randomized, hasten the prompt evaluation of new operations. Early clinical surveillance facilitates the design and implementation of randomized clinical trials when they are necessary. Of equal or greater importance, long-term surveillance of operations allows continuing evaluation when their use becomes widespread. Standards, coordination, review, and funding of the evaluation of new operations we believe should be centralized in a single national agency, for which an Institute of Health Care Assessment might be created. Implementation and regulation of the evaluation we believe should remain at the local or regional level with existing mechanisms and agencies being used, such as institutional human research committees and local health systems agencies. Copyright © 1978 AAAS.
引用
收藏
页码:937 / 941
页数:5
相关论文
共 46 条
[1]  
AMSTUTZ HC, 1973, SURGERY HIP JOINT, P656
[2]  
BARNES BA, 1977, COSTS RISKS BENEFITS, P107
[3]  
BLAKEMORE AH, 1946, B NEW YORK ACAD MED, V22, P254
[4]  
BLAKEMORE AH, 1952, SURG GYNECOL OBSTET, V94, P443
[5]  
BURTON DS, 1972, STANFORD MD, V11, P17
[6]  
Chalmers T C, 1972, Ann Thorac Surg, V14, P323
[7]  
CHARNLEY J, 1961, LANCET, V1, P1129
[8]  
CHILD C G 3rd, 1956, Am J Gastroenterol, V25, P148
[9]  
CHILD CG, 1952, MONOGRAPHS MEDICINE
[10]  
Cochran W. G., 1977, COSTS RISKS BENEFITS, P176